Abstract
Statins may be of potential benefit in patients with congestive heart failure (CHF) due to modulation of neurohormones and their antioxidant, antiinflammatory, and antifibrotic properties. To test this hypothesis, we performed a case-control study by using a prospective registry of patients admitted to our hospital for CHF. The Maastricht Registry of Congestive Heart Failure consists of a cohort of all patients who were admitted to the University Hospital Maastricht because of CHF for the first time between 1998 and 2000. Elective admissions were not included in the database. Drug treatment was left at the discretion of the attending physician. From a total of 840 patients admitted, we selected patients with an uncomplicated survival for at least 1 month after hospital discharge. For each survivor a nonsurvivor was matched for age, sex, left ventricular ejection fraction, and renal function. Drugs were considered in use only if they were administered for at least 90% of follow-up time. Five hundred twenty-four patients were included with a mean follow-up after discharge of 31 +/- 18 months. Twenty percent used statins. In Cox multivariate regression analysis, the use of statins remained significantly associated with decreased m...Continue Reading
References
Jun 8, 1999·Lancet·J NiebauerS D Anker
Nov 26, 1999·Circulation·G NickenigM Böhm
Oct 19, 2000·Lancet·M RauchhausS D Anker
Nov 18, 2000·Circulation·E Braunwald, M R Bristow
Aug 29, 2001·Circulation·J BauersachsG Ertl
Jan 26, 2002·Lancet·David A Grimes, Kenneth F Schulz
Feb 21, 2002·Circulation·Shunji HayashidaniAkira Takeshita
May 22, 2002·Journal of the American College of Cardiology·Henry Krum, John J McMurray
Apr 16, 2003·Circulation·Rainer U PliquettIrving H Zucker
Feb 21, 2004·Journal of the American College of Cardiology·Tamara B HorwichGregg C Fonarow
Mar 5, 2004·The American Journal of Cardiology·Aina HognestadUNKNOWN OPTIMAAL Investigators
Aug 11, 2004·European Journal of Heart Failure·Luigi TavazziUNKNOWN GISSI-HF Investigators
Citations
Aug 19, 2007·Heart Failure Reviews·Sofia G TsouliMoses S Elisaf
Aug 19, 2008·Current Atherosclerosis Reports·Jennifer Martin
Feb 21, 2009·Current Atherosclerosis Reports·Kumudha Ramasubbu, John A Farmer
Mar 24, 2007·Nature Clinical Practice. Cardiovascular Medicine·Michael J LipinskiGeorge W Vetrovec
Aug 20, 2011·International Journal of Clinical Practice·N Verma, V M Figueredo
Nov 28, 2013·Current Atherosclerosis Reports·Luisa De GennaroMatteo Di Biase
Mar 31, 2009·Journal of Cardiac Failure·Maral OuzounianDouglas S Lee
Dec 25, 2008·International Journal of Cardiology·Francisco M Gomez-SotoFrancisco Gomez
Oct 22, 2008·Cardiology Clinics·Prakash C Deedwania, Usman Javed
Jun 27, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Zeljko Reiner
Apr 25, 2008·Heart Failure Clinics·Hidekatsu Fukuta, William C Little
Apr 1, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Pablo F CastroSergio Lavandero
Feb 9, 2007·Pharmacology & Therapeutics·Juan TamargoEva Delpón
Aug 19, 2007·European Journal of Clinical Investigation·F Simko
Aug 22, 2006·British Journal of Pharmacology·J W Calvert, D J Lefer
Oct 17, 2012·Congestive Heart Failure·Mark R KahnTimothy J Vittorio
Jan 29, 2008·Journal of the American College of Cardiology·Kumudha RamasubbuDouglas L Mann
Apr 10, 2008·Seminars in Cardiothoracic and Vascular Anesthesia·Alexander Jc MittnachtSteven Konstadt
Feb 20, 2009·Current Opinion in Cardiology·Mouhannad M SadekHaissam Haddad
Mar 18, 2010·Nature Reviews. Cardiology·W H Wilson Tang, Gary S Francis
Feb 9, 2013·Postgraduate Medicine·James J DiNicolantonioJames H O'Keefe
Aug 23, 2019·Pharmacoepidemiology and Drug Safety·In-Sun OhJu-Young Shin
Jun 30, 2007·Clinical Science·Jennifer H Martin, Henry Krum